Ambys Medicines Inc.

Plus: Frías hired as CMO at Biomea Fusion, and updates from Astraveus and Septerna

Scripps spinout launches with $50M series A, $80M up front deal with Genentech to chase difficult targets

Plus new CBO, chief HR officer and head of regulatory at Prime, and SVP hires at CBM

The firm has backed 11 companies since the start of 2021; none are single-asset plays

Plus: SIB’s Durinx joins VIB, and updates from Orion, American Cancer Society, Ambys and more

Plus Clyburn leaving Merck & Co. and updates from Third Rock, BioTheryX, Ambys and more

Plus updates from Tessera, Oramed, Ikena and more

Metabolic and liver diseases company Genfit S.A. (Euronext:GNFT; NASDAQ:GNFT) hired Thomas Baetz as CFO. Baetz was director of healthcare at Dragon Financial Partners. Wolfgang Plischke will step down